Tag: DTG

Journalists Critical In ART Adherence Information Dissemination

Patricia Mashiri

Journalists have been identified as an important vehicle  in communicating and raising awareness around Antiretroviral Therapy (ART) adherence, a top government official has said. By Patricia Mashiri recently in Chinhoyi Speaking during a National AIDS Council (NAC) media workshop aimed at informing capacitating Journalists on HIV/AIDS reporting,  Dr John Mangwiro, the Deputy Minister of Health and Child Care said there was need to come up with innovative means of communicating the HIV and ART adherence message. I implore the media to have to make sure that it fulfills its developmental…

Pin
Share
Tweet
0 Shares
Read More

US Government Delivers 2, 1 Million Bottles Of TLD To Zim

Healthtimes

THE United States Government through USAID’s supply chain and procurement project has delivered 2, 1 million bottles of Tenofovir-Lamivudine-Dolutegravir (TLD) to Zimbabwe. By  Kudakwashe Pembere Zimbabwe transitioned to this new regimen with the Dolutegravir component in May 2018 said to have less side effects than Efavirenz. The United States Government USAID’s supply chain and procurement project has delivered 2.1 million bottles of TLD to support the transition to this new treatment regimen,” said USAID. Zimbabwe has about 1, 3 million people living with HIV with 1, 1 million placed on…

Pin
Share11
Tweet
11 Shares
Read More

Zimbos Now Buying ARVs In Zambia

Healthtimes

PEOPLE Living With HIV have resorted to buying Antiretroviral drugs from neighboring Zambia amidst fears of developing side effects from the expired stocks currently being dispensed in some health institutions. By Kudakwashe Pembere & Michael Gwarisa This is despite the assurance from the Medicines Control Authority of Zimbabwe (MCAZ) that the medicines have been tested and certified safe for consumption by people living with HIV. Speaking to HealthTimes on the sidelines of a march against ARV stock-outs,  Gumisai Bonzo a women living with HIV said they have organised groups to…

Pin
Share27
Tweet
27 Shares
Read More

Parliament Petitioned Over ARV Shortages

Michael Gwarisa

PEOPLE Living With HIV (PLHIV) have handed over a petition to the Parliament of Zimbabwe in a bid to push government to urgently allocate financial resources to arrest the prevailing drug shortage before the situation goes out of hand. By Michael Gwarisa The development comes at the back of indications that the National Aids Council (NAC) is sitting on a cash pile of RTGS$20 million which they are failing to convert to United States (US) dollars needed to procure drugs from source markets. In an interview on the side-lines of…

Pin
Share113
Tweet
113 Shares
Read More

DTG Won’t Be Forced On Citizens- Ministry

Michael Gwarisa

PEOPLE Living With HIV (PLHIV) and on Antiretroviral Therapy (ART) still have the option to continue taking other ART options apart from Dolutogravir (DTG) based regimens  since the process is not compulsory, a ministry of health and child care (MoHCC) official has said. By Michael Gwarisa in Gweru Zimbabwe commenced its transition process from Tenovir/Lamuvidene/Efavirens to Dolutegravir (DTG) in May 2019, and the transition procedure will be completed by February 2020. Briefing a women living with HIV, Sexual Reproductive Health and Rights (SRHR) workshop organised by PAPWC/ZIM,  ZWLHNF and UNAIDS,…

Pin
Share27
Tweet
27 Shares
Read More

Demystifying Dolutegravir based antiretroviral drug regimens

NewsRoom

ZIMBABWE recently joined other nations to adopt the new HIV treatment regimens that contain Dolutegravir (DTG).  The complete transition process for Zimbabwe however, will not take less than 10 months to be fully implemented considering that the country has over a million people on first line HIV medicines. By Michael Gwarisa and Dr. Simbarashe Mabaya Countries  adopt normative guidance by the World Health Organization (WHO) which is based on rigorous review and analysis of scientific evidence. Based on this review WHO develops recommendations which make up the next guidelines. Countries…

Pin
Share65
Tweet
65 Shares
Read More

Zim Commences DTG Drug Transition

NewsRoom

DEPUTY Director HIV/AIDS and STIs in the ministry of health and child care (MoHCC), Dr Tsitsi Apollo says the country has already commenced its transition process from Tenovir/Lamuvidene/Efavirens to Dolutegravir (DTG), a first line regimen of Antiretroviral Therapy (ART) which has less side effected and a rapid viral suppression. By Michael Gwarisa The whole transition process will be completed come February 2020 and in the process, drugs such as Navirapine (NVP) will be phased out with indications on the ground confirming that healthcare providers have already been advised to limit…

Pin
Share42
Tweet
42 Shares
Read More

Zim Defers HIV Drug Roll Out…Drug Deforms Unborn Babies

NewsRoom

THE Ministry of Health and Child Care (MoHCC) has deffered roll out of the HIV  Dolutegravir (DTG) drug  following indications that it causes complications in women of child bearing age and adolescent girls, which might lead to deformities in unborn babies born to HIV positive mothers taking the drug at the time of conception. HealthTimes Reporter Zimbabwe intended to scale up Dolutegravir as a first choice ARV to all people living with HIV in the country next year. The drug is currently being used to manage HIV in people who fail…

Pin
Share
Tweet
0 Shares
Read More